Tanaka K, Boice C R, Testa J R
Section of Cancer Genetics, University of Maryland Cancer Center, Baltimore 21201.
Cancer Genet Cytogenet. 1989 Nov;43(1):1-14. doi: 10.1016/0165-4608(89)90122-2.
Cytogenetic analysis was performed on 13 tumor specimens (six solid tissues and seven effusions) from nine patients with various types of ovarian cancer. Eight of these patients had not received cytotoxic therapy prior to the initial karyologic assessment. Extensive and complex numerical and structural alterations were seen in nearly all specimens. Consistent (clonal) abnormalities were found in each case, but karyotypic heterogeneity within a tumor was a consistent finding in this series. Aberrations of chromosomes 1, 3, 6, 7, 10, and 12 were each observed in five or more patients. Although no specific recurring translocations were observed, partial deletions of 3p, 6q, 8p, and 10q were each seen in three different cases. Breakpoints tended to recur at several chromosomal band regions, some of which appear to be near the known loci of certain protooncogenes. Double minute chromosomes were seen in one patient, and a homogeneously staining region was found in another. Karyotypic analysis was performed on one patient both before and after initiating chemotherapy, and the chromosome pattern became more complex after treatment. Overall, our findings indicate that karyotypes in newly diagnosed, untreated patients with ovarian cancer can be extremely complicated, and that the extent of chromosome change may increase with tumor progression. Furthermore, the recurrence of specific regional chromosome losses suggests that these sites contain genes whose loss plays a role in the formation of some ovarian tumors.
对9例不同类型卵巢癌患者的13个肿瘤标本(6个实体组织和7个积液)进行了细胞遗传学分析。其中8例患者在初次核型评估前未接受过细胞毒性治疗。几乎在所有标本中都观察到广泛而复杂的数量和结构改变。在每个病例中都发现了一致的(克隆性)异常,但肿瘤内的核型异质性在本系列中是一个一致的发现。1、3、6、7、10和12号染色体的畸变在5例或更多患者中均有观察到。虽然未观察到特定的反复出现的易位,但3p、6q、8p和10q的部分缺失在3个不同病例中均有发现。断点倾向于在几个染色体带区反复出现,其中一些似乎靠近某些原癌基因的已知位点。在1例患者中观察到双微体染色体,在另1例患者中发现了均匀染色区。对1例患者在化疗开始前后均进行了核型分析,治疗后染色体模式变得更加复杂。总体而言,我们的研究结果表明,新诊断的、未治疗的卵巢癌患者的核型可能极其复杂,并且染色体变化的程度可能随着肿瘤进展而增加。此外,特定区域染色体缺失的反复出现表明这些位点包含其缺失在某些卵巢肿瘤形成中起作用的基因。